Lv4
730 积分 2026-01-23 加入
P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW
29天前
已完结
Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years
29天前
已完结
Evaluating dental health risk assessment amongst bisphosphonate users
29天前
已关闭
Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study
29天前
已完结
CTX Biochemical Marker of Bone Metabolism. Is It a Reliable Predictor of Bisphosphonate-Associated Osteonecrosis of the Jaws After Surgery? Part II: A Prospective Clinical Study
29天前
已完结
Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation
29天前
已完结
Tooth extraction in osteoporotic patients taking oral bisphosphonates
29天前
已完结
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)
29天前
已完结
Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid – A prospective study over 6 years
29天前
已完结
Efficacy and risks of drug holiday in the management of medication-related osteonecrosis of the jaw in cancer patients: a single-center retrospective study
1个月前
已完结
皖公网安备34019202002308
